Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25 FibroBiologics, Inc. (NASDAQ:FBLG) is continuing preparations for a Phase 1/2 trial of CYWC628, a fibroblast-based spheroid product ...

Our Phase 1/2a clinical trial has demonstrated that the use of this stem cell population in humans is safe and effective in treating hard to heal diabetic foot ulcers." "We are extremely pleased ...

AI technologies hold immense potential to transform diabetes self-care by improving monitoring, enabling personalized ...

Caring for people with diabetic foot ulcers costs NHS England the region of £1 billion a year, but the developer of a new digital tool says it could help reduce the burden.

About 1 in 5 adults in middle and old age experiences ... Some foot conditions, particularly linked to diabetes, can be life-threatening. Diabetic foot ulcers have a five-year death rate of ...

AOTI announced on Tuesday that it has secured inclusion of its Topical Wound Oxygen (TWO2) therapy in the NHS Supply Chain ...

Diabetic foot infections can lead to severe complications, including amputation, which carries a high mortality rate. The promising results of BX211 suggest potential benefits in ulcer healing ...

A wearable smart insole tracks how you walk, run, and stand in real time—offering insights into posture, gait, and early ...

Action delays to January 1, 2026, the effective date of a Biden-era Medicare LCD for skin substitute products used to treat diabetic foot ulcers and venous leg ulcersFLORHAM PARK, N.J., April 14, 2025 ...

April is amputation prevention awareness month. Amputation rates are increasing in The Bahamas, the Caribbean and worldwide. In the United States, 160,000 people with diabetes undergo lower extremity ...